PTC Therapeutics Other Long Term Liabilities (Quarterly) Insights

PTC Therapeutics, Inc. (PTCT)

68.98 -1.52 (-2.16%) USD | NASDAQ | Feb 24, 16:00

69.48 +0.50 (+0.72%) After-Hours: 06:02

View Other Long Term Liabilities (Quarterly) for PTCT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

BioMarin Pharmaceutical, Inc.	Upgrade
Sarepta Therapeutics, Inc.	Upgrade
Ardelyx, Inc.	--
Spyre Therapeutics, Inc.	--
Ovid Therapeutics, Inc.	--